JP MORGAN/PUT/BECTON DICKINSON AND CO./235/0.1/17.01.25 Stock

Warrant

DE000JL1KNN8

Market Closed - Börse Stuttgart 03:06:35 2024-07-05 am EDT
2.3 EUR +1.77% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./235/0.1/17.01.25
Current month+5.50%
1 month+19.17%
Date Price Change
24-07-05 2.3 +1.77%
24-07-04 2.26 +0.89%
24-07-03 2.24 -1.75%
24-07-02 2.28 +9.09%
24-07-01 2.09 -4.13%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 03:06 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNN
ISINDE000JL1KNN8
Date issued 2023-04-05
Strike 235 $
Maturity 2025-01-17 (195 Days)
Parity 10 : 1
Emission price 1.91
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.47
Lowest since issue 1.75
Spread 0.1
Spread %4.24%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
227.8 USD
Average target price
278.9 USD
Spread / Average Target
+22.44%
Consensus